• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用一种肽靶向SOX2/CDP蛋白复合物可抑制食管鳞状细胞癌的恶性进展。

Targeting the SOX2/CDP protein complex with a peptide suppresses the malignant progression of esophageal squamous cell carcinoma.

作者信息

Chen Yunyun, Zhang Kun, Zhang Rui, Wang Zhuo, Yang Liang, Zhao Tingting, Zhang Shihui, Lin Yong, Zhao Hongzhou, Liu Yongpan, Wei Yuxuan, Zhou Yijian, Zhang Jiaying, Ye Xianzong, Zhao Jing, Li Xinxin, Que Jianwen, Shi Songlin, Liu Kuancan

机构信息

Central Laboratory, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, P. R. China.

School of Medicine, Xiamen University, Xiamen, Fujian, 361102, P. R. China.

出版信息

Cell Death Discov. 2023 Oct 27;9(1):399. doi: 10.1038/s41420-023-01693-7.

DOI:10.1038/s41420-023-01693-7
PMID:37891174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10611744/
Abstract

Emerging evidence indicates that SOX2 is an oncogene for esophageal squamous cell carcinoma (ESCC). However, direct targeting of SOX2 is not feasible given that this transcription factor plays important roles in the maintenance of tissues such as the brain. Here, we identified CDP (Homeobox protein cut-like 1 or CASP) as a unique SOX2 binding partner enriched in ESCC with Duolink proximity ligation assay, bimolecular fluorescence complementation (BiFc) and immunoprecipitation. We then screened a peptide aptamer library using BiFc and immunoprecipitation and identified several peptide aptamers, including P58, that blocked the CDP/SOX2 interaction, leading to the inhibition of ESCC progress in vitro and in vivo. Upon administration, synthetic peptide P58, containing the YGRKKRRQRRR cell-penetrating peptide and the fluorophore TAMRA, also blocked the growth and metastasis of ESCC in both mice and zebrafish. Therefore, targeting the SOX2 binding partner CDP with peptide P58 offers an alternative avenue to treat ESCC with increased SOX2 levels.

摘要

新出现的证据表明,SOX2是食管鳞状细胞癌(ESCC)的一种致癌基因。然而,鉴于这种转录因子在维持诸如大脑等组织中发挥重要作用,直接靶向SOX2是不可行的。在这里,我们通过Duolink邻近连接分析、双分子荧光互补(BiFc)和免疫沉淀,鉴定出CDP(同源框蛋白类切割样1或CASP)是一种在ESCC中富集的独特SOX2结合伴侣。然后,我们使用BiFc和免疫沉淀筛选了一个肽适配体文库,并鉴定出几种肽适配体,包括P58,它们阻断了CDP/SOX2相互作用,导致ESCC在体外和体内的进展受到抑制。给药后,含有YGRKKRRQRRR细胞穿透肽和荧光团TAMRA的合成肽P58也阻断了ESCC在小鼠和斑马鱼中的生长和转移。因此,用肽P58靶向SOX2结合伴侣CDP为治疗SOX2水平升高的ESCC提供了一条替代途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b2/10611744/4bde1586f307/41420_2023_1693_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b2/10611744/7fd658e8183d/41420_2023_1693_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b2/10611744/efb6001e475e/41420_2023_1693_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b2/10611744/0c82499c62cb/41420_2023_1693_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b2/10611744/6a58e53b55be/41420_2023_1693_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b2/10611744/44cc3fca60fe/41420_2023_1693_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b2/10611744/ec8617a84e25/41420_2023_1693_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b2/10611744/88b2be86cb78/41420_2023_1693_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b2/10611744/4bde1586f307/41420_2023_1693_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b2/10611744/7fd658e8183d/41420_2023_1693_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b2/10611744/efb6001e475e/41420_2023_1693_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b2/10611744/0c82499c62cb/41420_2023_1693_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b2/10611744/6a58e53b55be/41420_2023_1693_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b2/10611744/44cc3fca60fe/41420_2023_1693_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b2/10611744/ec8617a84e25/41420_2023_1693_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b2/10611744/88b2be86cb78/41420_2023_1693_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b2/10611744/4bde1586f307/41420_2023_1693_Fig8_HTML.jpg

相似文献

1
Targeting the SOX2/CDP protein complex with a peptide suppresses the malignant progression of esophageal squamous cell carcinoma.用一种肽靶向SOX2/CDP蛋白复合物可抑制食管鳞状细胞癌的恶性进展。
Cell Death Discov. 2023 Oct 27;9(1):399. doi: 10.1038/s41420-023-01693-7.
2
Targeting SOX2 Protein with Peptide Aptamers for Therapeutic Gains against Esophageal Squamous Cell Carcinoma.靶向 SOX2 蛋白的肽适体在治疗食管鳞癌中的应用。
Mol Ther. 2020 Mar 4;28(3):901-913. doi: 10.1016/j.ymthe.2020.01.012. Epub 2020 Jan 15.
3
Targeting the SOX2/PARP1 complex to intervene in the growth of esophageal squamous cell carcinoma.靶向 SOX2/PARP1 复合物干预食管鳞癌细胞生长。
Biomed Pharmacother. 2022 Sep;153:113309. doi: 10.1016/j.biopha.2022.113309. Epub 2022 Jun 20.
4
SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway.SOX2 通过 AKT/哺乳动物雷帕霉素靶蛋白复合物 1 信号通路促进食管鳞癌的肿瘤生长。
Cancer Sci. 2013 Jul;104(7):810-6. doi: 10.1111/cas.12155. Epub 2013 Apr 16.
5
GSK3β-driven SOX2 overexpression is a targetable vulnerability in esophageal squamous cell carcinoma.糖原合酶激酶3β驱动的SOX2过表达是食管鳞状细胞癌中一个可靶向的脆弱点。
Oncogene. 2023 Jul;42(30):2297-2314. doi: 10.1038/s41388-023-02748-w. Epub 2023 Jun 22.
6
Reciprocal regulation of LINC00941 and SOX2 promotes progression of esophageal squamous cell carcinoma.LINC00941 和 SOX2 的相互调控促进食管鳞状细胞癌的进展。
Cell Death Dis. 2023 Jan 30;14(1):72. doi: 10.1038/s41419-023-05605-6.
7
Chlorogenic acid inhibits esophageal squamous cell carcinoma growth in vitro and in vivo by downregulating the expression of BMI1 and SOX2.绿原酸通过下调 BMI1 和 SOX2 的表达抑制食管鳞癌细胞的体内外生长。
Biomed Pharmacother. 2020 Jan;121:109602. doi: 10.1016/j.biopha.2019.109602. Epub 2019 Nov 7.
8
TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.TP63、SOX2 和 KLF5 建立了一个核心调控回路,该回路控制食管鳞状细胞癌细胞系中的表观遗传和转录模式。
Gastroenterology. 2020 Oct;159(4):1311-1327.e19. doi: 10.1053/j.gastro.2020.06.050. Epub 2020 Jun 30.
9
The roles of the SOX2 protein in the development of esophagus and esophageal squamous cell carcinoma, and pharmacological target for therapy.SOX2 蛋白在食管及食管鳞癌发生发展中的作用及其药物治疗靶点。
Biomed Pharmacother. 2023 Jul;163:114764. doi: 10.1016/j.biopha.2023.114764. Epub 2023 Apr 24.
10
Stemness state regulators SALL4 and SOX2 are involved in progression and invasiveness of esophageal squamous cell carcinoma.干性状态调节因子SALL4和SOX2参与食管鳞状细胞癌的进展和侵袭。
Med Oncol. 2014 Apr;31(4):922. doi: 10.1007/s12032-014-0922-7. Epub 2014 Mar 22.

引用本文的文献

1
Potential biomarkers develop for predicting the prognosis of patients with esophageal squamous cell carcinoma after optimized chemoradiotherapy using serum metabolomics.利用血清代谢组学开发潜在生物标志物,用于预测食管鳞状细胞癌患者优化放化疗后的预后。
BMC Cancer. 2025 Mar 11;25(1):438. doi: 10.1186/s12885-025-13866-x.

本文引用的文献

1
HPV16 infection promotes the malignant transformation of the esophagus and progression of esophageal squamous cell carcinoma.HPV16 感染可促进食管恶性转化和食管鳞状细胞癌的进展。
J Med Virol. 2023 Oct;95(10):e29132. doi: 10.1002/jmv.29132.
2
The roles of the SOX2 protein in the development of esophagus and esophageal squamous cell carcinoma, and pharmacological target for therapy.SOX2 蛋白在食管及食管鳞癌发生发展中的作用及其药物治疗靶点。
Biomed Pharmacother. 2023 Jul;163:114764. doi: 10.1016/j.biopha.2023.114764. Epub 2023 Apr 24.
3
SOX2 inhibits LLGL2 polarity protein in esophageal squamous cell carcinoma via miRNA-142-3p.
SOX2 通过 miRNA-142-3p 抑制食管鳞癌细胞中的 LLGL2 极性蛋白。
Cancer Biol Ther. 2022 Dec 31;23(1):1-15. doi: 10.1080/15384047.2022.2126248.
4
Targeting the SOX2/PARP1 complex to intervene in the growth of esophageal squamous cell carcinoma.靶向 SOX2/PARP1 复合物干预食管鳞癌细胞生长。
Biomed Pharmacother. 2022 Sep;153:113309. doi: 10.1016/j.biopha.2022.113309. Epub 2022 Jun 20.
5
DTX-P7, a peptide-drug conjugate, is highly effective for non-small cell lung cancer.DTX-P7,一种肽类药物偶联物,对非小细胞肺癌具有高度疗效。
J Hematol Oncol. 2022 Jun 3;15(1):73. doi: 10.1186/s13045-022-01274-8.
6
Targeting SOX2 Protein with Peptide Aptamers for Therapeutic Gains against Esophageal Squamous Cell Carcinoma.靶向 SOX2 蛋白的肽适体在治疗食管鳞癌中的应用。
Mol Ther. 2020 Mar 4;28(3):901-913. doi: 10.1016/j.ymthe.2020.01.012. Epub 2020 Jan 15.
7
The inhibitory effect of compound ChlA-F on human bladder cancer cell invasion can be attributed to its blockage of SOX2 protein.化合物ChlA-F对人膀胱癌细胞侵袭的抑制作用可归因于其对SOX2蛋白的阻断。
Cell Death Differ. 2020 Feb;27(2):632-645. doi: 10.1038/s41418-019-0377-7. Epub 2019 Jun 26.
8
Dysregulated Tgfbr2/ERK-Smad4/SOX2 Signaling Promotes Lung Squamous Cell Carcinoma Formation.失调的 TGFBR2/ERK-SMAD4/SOX2 信号通路促进肺鳞癌的形成。
Cancer Res. 2019 Sep 1;79(17):4466-4479. doi: 10.1158/0008-5472.CAN-19-0161. Epub 2019 Jun 17.
9
Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer.食管癌的病因、癌症干细胞和潜在的诊断生物标志物。
Cancer Lett. 2019 Aug 28;458:21-28. doi: 10.1016/j.canlet.2019.05.018. Epub 2019 May 21.
10
Cullin5 deficiency promotes small-cell lung cancer metastasis by stabilizing integrin β1.Cullin5 缺失通过稳定整合素 β1 促进小细胞肺癌转移。
J Clin Invest. 2019 Mar 1;129(3):972-987. doi: 10.1172/JCI122779. Epub 2019 Jan 28.